FDA OIG Plans Review of FDA’s Regulatory Activity, According to New Work Plan Thomas Sullivan Dec 18, 2014 0 OIG Plans to Focus on How FDA Inspects Generic Manufacturers and Enforces Postmarketing and Clinical Trial Transparency…
